The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5293128 6105285 F 1 5293128-8 20060701 20070329 20070404 EXP 163-21880-06070753 CELGENE CORPORATION M N 20070329 OT 20060701 UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5293128 1008354735 PS REVLIMID 1 ORAL SEE IMAGE D D 21880

Indications of drugs used

Event ID DRUG SEQ INDI PT
5293128 1008354735 MYELODYSPLASTIC SYNDROME

Outcome of event

Event ID OUTC COD
5293128 DE
5293128 HO

Reactions reported

Event ID PT
5293128 DYSPNOEA

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
5293128 CR
5293128 HP

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5293128 1008354735 20060701
5293128 1008354735 20060101